None listed
Conditions
Brief summary
Asthma is the most common chronic condition affecting children. Education is an important part of asthma management; however, multiple studies have shown it is poorly done by health professionals and 90% of people with asthma are still not using their medication or devices correctly. It is clear there is a need for innovative ways for education to be delivered. Augmented reality (AR) may provide a generation appropriate, engaging modality for this. This research is part of a larger study, which aims to investigate if AR is an effective educational tool for children with asthma. The aim of this phase of the study is to design an optimal, functional and suitable AR tool for educational use. An AR tool will be created for use via a smartphone or tablet to deliver education in an innovative way. Participants in this study will be asked to trial the tool, and interviews will be undertaken with participants to determine the usability and appropriateness, as well as any barriers of its use. Participants will include children and teenagers with asthma, their parents, and the health professionals involved in their care.
Interventions
Via an external company and with input from health professionals, we will develop a smartphone and tablet application which can deliver asthma education and behavioural change tools via augmented reality (AR) which is the intervention being investigated. AR delivered via a smartphone or tablet application can superimpose digital information so that content seems to coexist within the real world, through delivering information through videos, graphs and animation. This application will function via pattern recognition of a paper-based poster, to trigger educational videos to activate, and initiate the paper-based poster to come to life on either the smartphone or tablet. The educational videos will cover indications for use of different asthma inhalers as well as correct technique of asthma inhalers. We will use current resources such as the Lung Foundation Australia ‘Stepwise Management of Stable COPD’ reference guide which uses similar technology, to underpin our intervention development. Participants will be recruitedd from three categories – children and adolescents with asthma (aged 8-17), parents/guardians of asthmatic children and adolescents, and health professionals who have treated asthma patients regularly for >12 months in the last 5 years. Individual participants will be shown a demonstration of how to use the same AR tool by one of the research investigators face to face, then be invited to also trial the use of it themselves. Qualitative data will be obtained through a once off semi-structured interview of approximately 45-60 minute duration per participant. During this time period, the participant will be shown a demonstration of how to use the AR smartphone/tablet application, then invited to trial the AR tool themselves. The AR tool will be trialled by the participant as a one-off during this time for a period of approximately 10-15 minutes. They will then be asked a range of questions about their opinions of the tool. Once the interview is complete, the participation in the study is complete. Demonstration and trial of the intervention, and interviews will be conducted at the Women's and Children's Hospital in Adelaide, South Australia. Interviews will be conducted by the principal investigator and co-investigators of the study. We will use the data obtained to amend the alpha version and create an optimal functional tool for a feasibility study. The aim in this study is to identify barriers and facilitators of the AR tool in this qualitative study and not to assess the effectiveness of the tool itself.
Sponsors
Study design
Eligibility
Inclusion criteria
Asthma community Inclusion criteria: Children and adolescents with a clinical diagnosis of asthma or a parent/guardian of an asthmatic child or adolescent Health professionals who have worked in their profession in South Australia (nursing staff, paediatric general medicine doctors, general practitioners, respiratory specialists, pharmacists and asthma educators) and have treated asthma patients regularly for >12 months in the last 5 years.
Exclusion criteria
Inability to consent Non-english speaking